H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.8% of adults in Oxnard have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Census population 202,063. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Oxnard clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Oxnard storefront.
Sports Injury Biologic Treatments in Oxnard, CA for clinics & physicians. Biologic treatments for sports i… Compliance support & pricing — contact Hawk Medical.
Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 12.8% of adults in Oxnard have diagnosed diabetes — 0.8 points above the U.S. 12% figure. 19.2% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick sports injury biologics against that mix.
National Sports Injury Biologic Treatments notes (how the product actually works)CDC PLACES (2023, crude) estimates 12.8% of adults in Oxnard have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Adult obesity in Oxnard is 28.4% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 17.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JE / Noridian Healthcare Solutions, sibling states HI, NV. California Department of Public Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy sports injury biologics elsewhere, use this page as a check: homologous-use language, current Noridian Healthcare Solutions article IDs, and PLACES 12.8% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 12.8% of adults — 0.8 points above the U.S. 12% figure. Obesity is 28.4%; arthritis is 17.6%. That is place-level BRFSS modeling, not a clinic census and not a Oxnard trial.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including California. There is no Oxnard storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including California.
We source from FDA-registered banks. Bank location is not the same as Hawk Medical’s distribution address, and it is not a Oxnard clinic. Ask for the bank’s registration and AATB status on the SKU you want.
Ask for the IFU, the lot-traceability packet, and the Noridian Healthcare Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Oxnard fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Oxnard, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Oxnard is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Oxnard — 0.8 points above the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Oxnard. Useful for joint-program math; still needs a diagnosis and privileging.
No Oxnard storefront. Joe Bradley is an active practice owner. sports injury biologics stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.